These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7561033)

  • 1. Human B cell activation. Effect of T cell cytokines on the physicochemical binding requirements for achieving cell cycle progression via the membrane IgM signaling pathway.
    Mongini PK; Highet PF; Inman JK
    J Immunol; 1995 Oct; 155(7):3385-400. PubMed ID: 7561033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane IgM-stimulated human B lymphocytes succumb to activation-related apoptosis at a G1-->S transition: influence of ligand affinity and valency.
    Mongini PK; Vilensky MA; Highet PF; Inman JK
    Cell Immunol; 1998 Sep; 188(2):137-50. PubMed ID: 9756644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane IgM-mediated signaling of human B cells. Effect of increased ligand binding site valency on the affinity and concentration requirements for inducing diverse stages of activation.
    Mongini PK; Blessinger CA; Highet PF; Inman JK
    J Immunol; 1992 Jun; 148(12):3892-901. PubMed ID: 1376344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane IgD and membrane IgM differ in capacity to transduce inhibitory signals within the same human B cell clonal populations.
    Mongini PK; Blessinger C; Posnett DN; Rudich SM
    J Immunol; 1989 Sep; 143(5):1565-74. PubMed ID: 2788188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity requirements for induction of sequential phases of human B cell activation by membrane IgM-cross-linking ligands.
    Mongini PK; Blessinger CA; Dalton JP
    J Immunol; 1991 Mar; 146(6):1791-800. PubMed ID: 2005379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine dependency of human B cell cycle progression elicited by ligands which coengage BCR and the CD21/CD19/CD81 costimulatory complex.
    Mongini PK; Inman JK
    Cell Immunol; 2001 Feb; 207(2):127-40. PubMed ID: 11243702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell activation. V. Differentiation signaling of B cell membrane depolarization, increased I-A expression, G0 to G1 transition, and thymidine uptake by anti-IgM and anti-IgD antibodies.
    Cambier JC; Monroe JG
    J Immunol; 1984 Aug; 133(2):576-81. PubMed ID: 6610706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monovalent C mu 4-specific ligand enhances the activation of human B cells by membrane IgM cross-linking ligands.
    Mongini PK; Blessinger CA; Chiorazzi N; Rajaram N; Rudich SM
    Int Immunol; 1995 Feb; 7(2):317-30. PubMed ID: 7734425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-10 inhibits lipopolysaccharide-induced murine B cell proliferation and cross-linking of surface antigen receptors or ligation of CD40 restores the response.
    Marcelletti JF
    J Immunol; 1996 Oct; 157(8):3323-33. PubMed ID: 8871628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CR2 ligands modulate human B cell activation.
    Bohnsack JF; Cooper NR
    J Immunol; 1988 Oct; 141(8):2569-76. PubMed ID: 2459218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The affinity threshold for human B cell activation via the antigen receptor complex is reduced upon co-ligation of the antigen receptor with CD21 (CR2).
    Mongini PK; Vilensky MA; Highet PF; Inman JK
    J Immunol; 1997 Oct; 159(8):3782-91. PubMed ID: 9378965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of cell cycle entry and G1 progression by CSF-1.
    Roussel MF
    Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separate control of B lymphocyte early activation and proliferation in response to anti-IgM antibodies.
    DeFranco AL; Raveche ES; Paul WE
    J Immunol; 1985 Jul; 135(1):87-94. PubMed ID: 3873499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T cells require IL-2 but not G1/S transition to acquire susceptibility to Fas-mediated apoptosis.
    Fournel S; Genestier L; Robinet E; Flacher M; Revillard JP
    J Immunol; 1996 Nov; 157(10):4309-15. PubMed ID: 8906804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial lipoproteins may substitute for cytokines in the humoral immune response to T cell-independent type II antigens.
    Snapper CM; Rosas FR; Jin L; Wortham C; Kehry MR; Mond JJ
    J Immunol; 1995 Dec; 155(12):5582-9. PubMed ID: 7499841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ligand-induced membrane IgM association with the cytoskeletal matrix of B cells is not mediated through the Ig alpha beta heterodimer.
    Hartwig JH; Jugloff LS; De Groot NJ; Grupp SA; Jongstra-Bilen J
    J Immunol; 1995 Oct; 155(8):3769-79. PubMed ID: 7561081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth regulation of a human mature B cell line, B104, by anti-IgM and anti-IgD antibodies.
    Kim KM; Yoshimura T; Watanabe H; Ishigami T; Nambu M; Hata D; Higaki Y; Sasaki M; Tsutsui T; Mayumi M
    J Immunol; 1991 Feb; 146(3):819-25. PubMed ID: 1988498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric C3dg primes human B lymphocytes for proliferation induced by anti-IgM.
    Carter RH; Fearon DT
    J Immunol; 1989 Sep; 143(6):1755-60. PubMed ID: 2528579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular events in B cell activation. I. Signals required to stimulate G0 to G1 transition of resting B lymphocytes.
    Monroe JG; Kass MJ
    J Immunol; 1985 Sep; 135(3):1674-82. PubMed ID: 2410499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.